Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States


News provided by

PTK SOLUTIONS CO.,LTD

Oct 09, 2026, 04:43 ET

Share this article

Share toX

Share this article

Share toX

HO CHI MINH CITY, Vietnam, Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the treatment pathway it uses for patients who travel to Vietnam for care. The clinic treats lower limb venous insufficiency with minimally invasive methods: Endovenous Laser Ablation (EVLA), Ultrasound-Guided Foam Sclerotherapy (UGFS), superficial sclerotherapy, and Muller's ambulatory phlebectomy. Treatment follows standardized medical protocols and is carried out by vascular specialists. Procedures are performed on an outpatient basis, so most patients are discharged the same day and return to routine daily activities without a hospital stay. Alongside patients living in Vietnam, the clinic treats international patients and Vietnamese expatriates returning home for treatment. Details of what influences the total cost are published in the clinic's guide to varicose vein treatment in Vietnam.

The Specialist Team Behind the Treatment

Treatment at Dr. Vein is carried out by vascular surgeons licensed to practice in Vietnam, working exclusively in venous disease. The team brings more than ten years of training and clinical practice at Cho Ray Hospital, one of Vietnam's largest tertiary referral centers. Their professional background and training encompass specialized vein and peripheral arterial interventions in Singapore in 2019, clinical tenure in the Department of Vascular Surgery at Cho Ray Hospital, and continuing medical education in radiofrequency and laser treatment of lower limb venous insufficiency at the same institution.

Notably, in 2026, the clinic's specialists furthered their clinical training and professional exchange in venous and arterial care in the United States, working and studying alongside leading surgical and cardiovascular experts at Michigan Medicine and the Frankel Cardiovascular Center of the University of Michigan.

Michigan Medicine is the academic medical system and medical school of the University of Michigan, recognized as a premier academic medical center in the United States. Through this program, the specialists exchanged expertise with esteemed professors and leaders in the field, including Peter Henke, M.D., Director of the Frankel Cardiovascular Center, and Jonathan Lee Eliason, M.D., gaining exposure to advanced methodologies and techniques in vascular surgery and intervention—spanning venous disease management, arterial interventions, and revascularization techniques. This engagement forms part of the team's ongoing commitment to continuous professional advancement, with a dedicated clinical focus on the diagnosis and treatment of lower limb venous disease at Dr. Vein.

In venous disease specifically, the clinic's specialists have performed more than 1,800 UGFS procedures, more than 2,000 sclerotherapy procedures, more than 1,000 EVLA procedures, and more than 500 phlebectomy and branch ligation procedures. Further detail on the clinic and its team is published on the Dr. Vein clinic profile.

Dr. Vein Specialized Vein Treatment Center

Dr. Vein was founded around a vascular surgical team trained at Cho Ray Hospital, and is dedicated to providing specialized treatment for venous insufficiency for both local and international patients. The clinic works to a core principle of treating the source of venous reflux in order to improve treatment efficacy and reduce the risk of recurrence. Care is delivered by qualified and experienced doctors who work only in this field.

Minimally Invasive Vein Treatment Methods at Dr. Vein

Depending on the location of the affected veins, disease progression, clinical symptoms and ultrasound findings, the physician will prescribe an appropriate treatment method or a combination of therapies, with the aim of achieving a good result and reducing the risk of recurrence.

For patients who also present with joint conditions or radicular nerve pain, the clinic conducts multidisciplinary consultation. This matters because aching, heaviness and night cramps in the legs are not specific to venous disease. The purpose of the consultation is to identify whether the pain originates in the veins, the musculoskeletal system or the nerves, so that the treatment plan addresses the condition actually causing the symptoms rather than the one that is easiest to see.

Current varicose vein treatment options at Dr. Vein include:

  • Endovenous Laser Ablation (EVLA): laser energy is applied to the diseased vein wall to collapse and seal the vessel. Blood flow is then rerouted naturally through surrounding healthy veins.
  • Ultrasound-Guided Foam Sclerotherapy (UGFS): under ultrasound guidance, the physician injects a sclerosant into the affected vein, causing it to fibrose so that the diseased vessel is eliminated.
  • Superficial sclerotherapy: used for small superficial veins, spider veins and reticular veins.
  • Microphlebectomy (Muller's method): a surgical technique that removes superficial, tortuous varicose veins through micro incisions or needle punctures in the skin, designed to leave minimal marks on the skin.

What a Treatment Trip Involves for a Patient Travelling from Abroad

For patients flying in, the limiting factor is usually not the procedure but the calendar. The clinic therefore plans treatment around the length of the stay. A published case from the clinic illustrates the sequence. A patient in her fifties, living abroad and working in a role that required prolonged standing, presented with varicose vein clusters on both thighs and lower legs that had been developing for two to three years, with fatigue, aching and occasional cramps, and no improvement from compression stockings.

Duplex Doppler ultrasound performed by the treating specialist recorded reflux in the great saphenous veins of both legs with a reflux time of more than four seconds, and the case was classified as lower limb venous insufficiency, stage C2 on the CEAP classification. Treatment combined EVLA to seal the refluxing great saphenous segments with UGFS for the larger dilated branches, and was divided into two stages approximately one week apart to allow recovery between them and to prepare for a long flight home. The procedures were performed under procedural sedation on an outpatient basis.

Patients are told in advance what to expect afterwards. Treated veins commonly feel firm or show mild bruising for a period, which is part of the process by which the body clears the closed vein. Aftercare guidance covers walking and gentle ankle exercises to support the calf muscle pump, Grade 1 medical compression stockings during long periods of standing or sitting, limiting squatting and sitting cross-legged, and keeping body weight stable. Documented outcomes from treated cases are published at documented patient outcomes.

How the Cost Compares with Treatment in the United States

Cost is the first question most international patients ask, and the clinic publishes how it is built up rather than a single headline figure, because the total depends on the severity and extent of the venous disease, the number of segments treated and the combination of techniques used. According to the clinic's published cost guide, a single EVLA procedure in many Western healthcare systems is often priced between 3,000 and 4,000 US dollars, and patients can wait three to six months for an appointment. The clinic states that its own fees are substantially lower while using the same FDA approved technologies, and that treatment is quoted with the diagnostic assessment and the component services set out in advance. Because every case differs, a specific quotation follows the Doppler ultrasound assessment rather than preceding it.

One structural reason for the difference is that all interventions at Dr. Vein are performed on an outpatient basis under local anesthesia, which removes operating room and inpatient costs that traditional vein stripping surgery carries.

How the Approach Compares with International Guidelines

The methods used at Dr. Vein are the ones recommended in current international practice guidelines. The 2022 clinical practice guidelines issued jointly by the Society for Vascular Surgery, the American Venous Forum and the American Vein and Lymphatic Society give a Grade 1 recommendation, their strongest, for endovenous ablation over high ligation and stripping in patients with symptomatic varicose veins and axial reflux in the great or small saphenous vein, citing less postprocedure pain and morbidity and an earlier return to regular activity. The United Kingdom's National Institute for Health and Care Excellence reaches a comparable conclusion in guideline CG168, which places endothermal ablation first among treatment options for confirmed symptomatic varicose veins. Patients can therefore compare the treatment offered in Ho Chi Minh City against the standard of care published in their own country.

Language Support and Continuity of Care for International Patients

For international patients visiting Dr. Vein, the clinic provides dedicated interpreters. The vascular surgical team also communicates in English, so that patients understand the underlying cause of their condition, their own clinical findings and the treatment options available to them. Physicians provide tailored lifestyle guidance intended to support recovery, reduce the risk of recurrence and shorten overall treatment time. Patients travelling from abroad can read how treatment is arranged before they book.

Independent Press Coverage

Dr. Vein has been reported on by Vietnamese national news outlets. Six articles across five publications, Znews, Thanh Nien, VnExpress, VnExpress International and Tien Phong, link directly to the clinic. English language coverage is available from VnExpress International. The full list, with links to each original article, is published at drvein.vn/en/press.

About Dr. Vein

Dr. Vein, which also operates under the name Edopi Health Care, is a clinic in Ho Chi Minh City, Vietnam, working exclusively in the diagnosis and treatment of lower limb venous disease. It treats venous insufficiency, varicose veins, spider veins and related complications using duplex Doppler ultrasound assessment followed by minimally invasive intervention, on an outpatient basis. The clinic serves patients in Vietnam and international patients travelling for treatment.

Dr. Vein Clinic Contact Information

  • Address: 2 Noi Khu My Toan 2 (H4-1), Tan Hung Ward, Ho Chi Minh City, Vietnam
  • Phone: +84 93 219 28 82
  • Website: https://drvein.vn/en/
  • Press coverage: https://drvein.vn/en/press
  • Business hours: Monday to Saturday, 8:00 to 17:00 Indochina Time

SOURCE PTK SOLUTIONS CO.,LTD

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.